Argenx
ARGX
#536
Rank
HK$302.42 B
Marketcap
HK$4,977
Share price
-1.83%
Change (1 day)
61.76%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -HK$32.59

According to Argenx 's latest financial reports the company's current EPS (TTM) is -HK$32.38. In 2022 the company made an earnings per share (EPS) of -HK$102.13.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$32.59-68.09%
2022-HK$102.13